Day: February 21, 2021

— 1stapproval of any checkpoint inhibitor in nasopharyngeal carcinoma in the world— 2ndindication approved for Toripalimab in ChinaSHANGHAI, China, Feb. 22, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the National Medical Products Administration (NMPA) of China has granted a conditional approval to toripalimab for the treatment of patients with recurrent or metastatic nasopharyngeal carcinoma (NPC) after failure of at least two lines of prior systemic therapy. This is the first approval of immune checkpoint blockade therapy in NPC in the world and the second approved indication for toripalimab in China. In December 2018, Toripalimab obtained...

MANAGEMENT COMMENTARYSecond half of 2020 is characterized by continuation of COVID crisis. Salmon prices are 12-year low and compared to the same period last year, salmon prices are down 38% and rainbow trout is down by 22.5%. Adding to this global decrease in demand due to shutdown of HoReCa and you can call the situation as „perfect storm“. Companies who emerge from this crisis unscathed will be future winners. Arrival of vaccines is giving hope that we can see some normalization during 2nd half of 2021. 2022 will definitely be more profitable year in Fish farming as farmers can plan better the demand. Today’s farming volumes were planned before crisis and therefore there is massive oversupply in the market and most Fish farmers operate either at loss or at break-even. John Ross Jr has shown extraordinary resilience in current crisis...

JUHTKONNA KOMMENTAAR2020 II poolaastat ilmestas COVID kriisi jätkumine. Lõheliste hinnad on 12- aasta madalaimad ning võrreldes eelmise aasta sama perioodiga ligi 38% madalam lõhel ning 22.5% madalam forellil. Siia tuleb veel lisada ülemaailmne nõudluse vähenemine HoReCa sektori sulgemise tõttu ning seega võib antud olukorda nimetada „täiuslik torm“. Ettevõtted, kes sellest kriisist väljuvad tervelt, on kindlasti tulevikus võitjad. Vaktsiinide tulek annab lootust, et 2021 II poolaastas võime näha mingit normaliseerumist ning nõudluse taastumist. 2022 on kalakasvatustel kindlasti kasumlikum aasta, sest kasvatajad oskavad paremini nõudlust planeerida. Tänased kasvatusmahud olid planeeritud enne kriisi ning sellest tulenevalt on turul massiivne ülepakkumine ning enamus kalakavatussektorist toimib kas kahjumlikult või omahinna piires. John...

The Practus Board announced the appointment of Deepak Narayanan as CEO with immediate effect. Founded by S. Venkataraman and Deepak Narayanan, Practus with presence across North America, the Middle East, Africa & India (operates under the brand name MYCFO and MyCXO), is a leading Business and Finance Advisory firm, that assists the clients to transform their Finance and Business operations. The CEO appointment will accelerate the group expansion to the next level of growth, aided by faster decision-making, a responsibility which was jointly shouldered by the Co-Founders till date “Practus has been growing rapidly, and as we enter new markets and explore new territories, given Deepak’s strong command over the business and proven ability to drive results, makes him the right person to provide a focused, responsive, and decisive direction...